Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $428.76 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $167.37 | 9 | $0 (2022) |
| ABBVIE INC. | $106.52 | 5 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $97.75 | 2 | $0 (2022) |
| Medtronic USA, Inc. | $34.42 | 2 | $0 (2020) |
| Merz Pharmaceuticals, LLC | $22.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.00 | 3 | ABBVIE INC. ($36.30) |
| 2023 | $47.87 | 2 | ABBVIE INC. ($47.87) |
| 2022 | $129.81 | 4 | Ipsen Biopharmaceuticals, Inc ($78.76) |
| 2021 | $18.79 | 1 | Allergan, Inc. ($18.79) |
| 2020 | $34.54 | 2 | Allergan, Inc. ($18.67) |
| 2019 | $118.62 | 6 | Allergan Inc. ($81.08) |
| 2018 | $20.13 | 1 | Allergan Inc. ($20.13) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/07/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Musculoskeletal | ||||||
| 03/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/06/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $78.76 | General |
| Category: Neurology | ||||||
| 02/25/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/18/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: SPASTICITY | ||||||
| 10/13/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: SPASTICITY | ||||||
| 02/27/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: SPASTICITY | ||||||
| 01/08/2020 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Drug Infusion Systems | ||||||
| 12/04/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2019 | Medtronic USA, Inc. | SYNCHROMED (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Drug Infusion Systems | ||||||
| 08/08/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neurology | ||||||
| 01/24/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2018 | Allergan Inc. | BOTOX - SPASTICITY (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: SPASTICITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 566 | 5,121 | $332,495 | $91,449 |
| 2022 | 13 | 517 | 8,903 | $409,129 | $109,804 |
| 2021 | 19 | 651 | 7,257 | $384,003 | $105,740 |
| 2020 | 13 | 624 | 1,351 | $371,300 | $97,834 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 4,200 | $71,400 | $20,596 | 28.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 129 | 311 | $68,731 | $19,026 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 160 | $37,120 | $14,959 | 40.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 51 | 66 | $21,054 | $5,986 | 28.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 40 | 40 | $24,840 | $5,445 | 21.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 43 | 63 | $17,136 | $4,622 | 27.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 31 | 32 | $10,464 | $2,805 | 26.8% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 12 | 23 | $14,306 | $2,577 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 40 | $6,800 | $2,573 | 37.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 15 | 15 | $9,075 | $2,013 | 22.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 12 | 12 | $8,820 | $1,971 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,110 | $1,688 | 33.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 39 | $4,680 | $1,523 | 32.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 16 | 36 | $6,408 | $1,431 | 22.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 14 | 14 | $6,342 | $1,423 | 22.4% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 19 | 30 | $14,370 | $1,224 | 8.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,629 | $872.70 | 33.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 14 | 15 | $3,210 | $713.41 | 22.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 7,900 | $134,300 | $38,652 | 28.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 136 | 474 | $104,754 | $26,271 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 123 | $28,536 | $11,477 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 116 | $37,004 | $9,295 | 25.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 51 | 53 | $32,913 | $8,219 | 25.0% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 14 | 27 | $16,794 | $3,239 | 19.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 38 | 38 | $12,426 | $3,038 | 24.4% |
About Dr. Somkiat Hemtasilpa, M.D
Dr. Somkiat Hemtasilpa, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013974237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Somkiat Hemtasilpa, M.D has received a total of $428.76 in payments from pharmaceutical and medical device companies, with $59.00 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($428.76).
As a Medicare-enrolled provider, Hemtasilpa has provided services to 2,358 Medicare beneficiaries, totaling 22,632 services with total Medicare billing of $404,827. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Wyomissing, PA
- Active Since 05/01/2006
- Last Updated 03/26/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1013974237
Products in Payments
- BOTOX (Biological) $172.68
- DYSPORT (Drug) $97.75
- BOTOX (Drug) $81.08
- SYNCHROMED (Device) $34.42
- Xeomin (Biological) $22.70
- BOTOX - SPASTICITY (Drug) $20.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Wyomissing
Haiping Mei, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,696
Li-Hong Lu, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,263
Kelley Crozier, Md, MD
Physical Medicine & Rehabilitation — Payments: $730.41
Sanghoon Kim, Md, MD
Physical Medicine & Rehabilitation — Payments: $588.08
Paul Brockman, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $435.07
Mary Elmer
Physical Medicine & Rehabilitation — Payments: $215.26